US Patent Issued to Incyte, Incyte Holdings on May 12 for "Topical formulation for a JAK inhibitor" (Pennsylvania, Texas Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,908, issued on May 12, was assigned to Incyte Corp. (Wilmington, Del.) and Incyte Holdings Corp. (Wilmington, Del.).

"Topical formulation for a JAK inhibitor" was invented by Bhavnish Parikh (Avondale, Pa.), Bhavesh Shah (San Antonio) and Krishnaswamy Yeleswaram (Landenberg, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders."

The patent was filed on Dec. 3, 2021, under Application...